Stock Update: Allergan Inc (NYSE:AGN) – The Zacks Analyst Blog Highlights: Actavis, Allergan, iShares U.S. Pharmaceuticals ETF, Market Vectors Pharmaceutical ETF and SPDR S&P Pharmaceuticals ETF

[Zacks] – The Zacks Analyst Blog Highlights: Actavis, Allergan, iShares U.S. Pharmaceuticals ETF, Market Vectors Pharmaceutical ETF and SPDR S&P Pharmaceuticals ETF Read more on this. Allergan Inc. (AGN), valued at $63.53B, . . . → Read More: Stock Update: Allergan Inc (NYSE:AGN) – The Zacks Analyst Blog Highlights: Actavis, Allergan, iShares U.S. Pharmaceuticals ETF, Market Vectors Pharmaceutical ETF and SPDR S&P Pharmaceuticals ETF Similar Articles: Company Update: Allergan Inc (NYSE:AGN) – Allergan Comments on Valeant Letter Market Update (NYSE:AGN): Allergan Issues Statement Regarding Recent Valeant Correspondence Company Update (NYSE:AGN): Allergan Provides Update on Written Requests from Pershing Square Regarding Special Meeting of Stockholders